Arvinas Ownership | Who Owns Arvinas?

Overview Forecast RevenueFinancials Chart Transcripts

Arvinas Ownership Summary

Arvinas is owned by 88.35% institutional investors, 6.75% insiders, and 4.90% retail investors. Vanguard group is the largest institutional shareholder, holding 9.80% of ARVN shares. BB Biotech AG Ord is the top mutual fund, with 3.46% of its assets in Arvinas shares.

ARVN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Arvinas	88.35%	6.75%	4.90%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	7.06M	9.80%	$135.39M
Blackrock funding, inc. /de	6.57M	9.11%	$125.87M
Blackrock	6.26M	8.70%	$166.61M
Price t rowe associates inc /md/	4.10M	5.69%	$78.66M
Pfizer	3.46M	4.80%	$66.29M
Rtw investments, lp	3.33M	4.64%	$63.92M
T. rowe price investment management	2.21M	3.06%	$42.33M
Ubs group	2.04M	2.83%	$39.08M
Jpmorgan chase	1.86M	2.58%	$35.60M
State street	1.64M	2.28%	$31.38M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
New leaf venture partners	1.59M	40.64%	$30.40M
Aquilo capital management	328.77K	9.50%	$6.30M
Opaleye management	1.63M	5.89%	$33.64M
Nextech invest	1.41M	4.38%	$27.00M
Exome asset management	218.70K	3.15%	$4.19M
Pfizer	3.46M	2.56%	$66.29M
Avidity partners management lp	1.36M	2.56%	$26.03M
Rtw investments, lp	3.33M	0.97%	$63.92M
Boxer capital	608.61K	0.85%	$16.20M
Finepoint capital lp	713.78K	0.84%	$13.68M

Top Buyers

Holder	Shares	% Assets	Change
Pfizer	3.46M	2.56%	3.46M
T. rowe price investment management	2.21M	0.03%	2.21M
Ubs group	2.04M	0.01%	1.57M
Norges bank	1.24M	0.00%	1.24M
Blackrock	6.26M	0.00%	764.55K

Top Sellers

Holder	Shares	% Assets	Change
Ecor1 capital	-	-	-6.73M
Bellevue group	-	-	-2.39M
Paradigm biocapital advisors lp	-	-	-2.34M
Arrowmark colorado	-	-	-1.78M
Fmr	1.56M	0.00%	-1.32M

New Positions

Holder	Shares	% Assets	Change	Value
Pfizer	3.46M	2.56%	3.46M	$66.29M
T. rowe price investment management	2.21M	0.03%	2.21M	$42.33M
Norges bank	1.24M	0.00%	1.24M	$23.84M
Caption management	206.91K	0.04%	206.91K	$3.97M
Edmond de rothschild	80.00K	0.03%	80.00K	$1.53M

Sold Out

Holder	Change
Capital performance advisors llp	-6.00
Clearstead advisors	-13.00
Cornerstone planning group	-17.00
Capital advisors	-28.00
Avion wealth	-33.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	227	7.08%	64,055,484	-16.35%	88	0.78%	127	13.39%	58	13.73%
Dec 31, 2024	208	-4.59%	76,287,067	7.32%	105	1.09%	111	9.90%	51	-22.73%
Sep 30, 2024	217	3.33%	71,015,986	0.13%	98	1.01%	99	-18.18%	67	26.42%
Jun 30, 2024	210	-7.89%	70,926,259	4.97%	98	1.11%	121	-	53	-18.46%
Mar 31, 2024	228	3.64%	67,567,208	4.28%	94	0.84%	121	-20.39%	65	51.16%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
BB Biotech AG Ord	2.38M	3.46%	-
Vanguard Total Stock Mkt Idx Inv	2.05M	2.82%	114.30K
Vanguard US Total Market Shares ETF	1.93M	2.81%	2.43K
T. Rowe Price New Horizons	1.89M	2.74%	-128.42K
US Small-Cap Growth II Equity Comp	1.89M	2.74%	-129.00K
iShares Russell 2000 ETF	1.64M	2.25%	804.00
Vanguard Small Cap Index	1.56M	2.14%	18.09K
Vanguard Institutional Extnd Mkt Idx Tr	1.01M	1.38%	2.09K
Vanguard Explorer Inv	871.97K	1.19%	-332.49K
Vanguard Small Cap Growth Index Inv	865.58K	1.19%	1.87K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 18, 2025	Berkowitz Noah	Chief Medical Officer	Sell	$74.37K
Feb 24, 2025	Loomis David K	Chief Accounting Officer	Sell	$20.33K
Feb 24, 2025	Cacace Angela M	Chief Scientific Officer	Sell	$51.27K
Feb 24, 2025	Cacace Angela M	Chief Scientific Officer	Sell	$18.97K
Feb 24, 2025	Taylor Ian	President, R&D	Sell	$123.21K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	8
2024 Q4	-	1
2024 Q2	-	-
2024 Q1	-	4
2023 Q3	-	1

ARVN Ownership FAQ

Who Owns Arvinas?

Arvinas shareholders are primarily institutional investors at 88.35%, followed by 6.75% insiders and 4.90% retail investors. The average institutional ownership in Arvinas's industry, Biotech Stocks , is 63.96%, which Arvinas exceeds.

Who owns the most shares of Arvinas?

Arvinas’s largest shareholders are Vanguard group (7.06M shares, 9.80%), Blackrock funding, inc. /de (6.57M shares, 9.11%), and Blackrock (6.26M shares, 8.70%). Together, they hold 27.61% of Arvinas’s total shares outstanding.

Does Blackrock own Arvinas?

Yes, BlackRock owns 8.70% of Arvinas, totaling 6.26M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 166.61M$. In the last quarter, BlackRock increased its holdings by 764.55K shares, a 13.92% change.

Who is Arvinas’s biggest shareholder by percentage of total assets invested?

New leaf venture partners is Arvinas’s biggest shareholder by percentage of total assets invested, with 40.64% of its assets in 1.59M Arvinas shares, valued at 30.4M$.

Who is the top mutual fund holder of Arvinas shares?

BB Biotech AG Ord is the top mutual fund holder of Arvinas shares, with 3.46% of its total shares outstanding invested in 2.38M Arvinas shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools